(Q39664069)

13 September 2017

title

Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism (English)

1 reference

13 September 2017

Yanling Chen

1

1 reference

13 September 2017

Lei Jiang

2

1 reference

13 September 2017

Feifei She

3

1 reference

13 September 2017

Nanhong Tang

4

1 reference

13 September 2017

Xiaoqian Wang

5

1 reference

13 September 2017

Xiujin Li

6

1 reference

13 September 2017

Shenghua Han

7

1 reference

13 September 2017

Jinhai Zhu

8

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20734221

21 June 2024

publication date

25 August 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s11010-010-0562-y.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0562-Y

http://link.springer.com/article/10.1007/s11010-010-0562-y/fulltext.html

21 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0562-Y

http://link.springer.com/content/pdf/10.1007/s11010-010-0562-y

21 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0562-Y

Molecular and Cellular Biochemistry

21 June 2024

published in

1 reference

13 September 2017

volume

345

1 reference

13 September 2017

issue

1-2

1 reference

13 September 2017

page(s)

77-89

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-010-0562-y

13 September 2017

exact match

0 references

cites work

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0562-Y

Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0562-Y

Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma

21 January 2018

1 reference

12 December 2020

[Expressions of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinoma].

1 reference

12 December 2020

Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3

1 reference

12 December 2020

Lymphatic metastasis in the absence of functional intratumor lymphatics

1 reference

12 December 2020

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis

1 reference

12 December 2020

Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops

1 reference

12 December 2020

Long-term results after resection for gallbladder cancer. Implications for staging and management

1 reference

12 December 2020

Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.

1 reference

12 December 2020

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma

1 reference

12 December 2020

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

1 reference

12 December 2020

VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.

1 reference

12 December 2020

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma

1 reference

12 December 2020

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

1 reference

12 December 2020

A potential autocrine role for vascular endothelial growth factor in prostate cancer.

1 reference

12 December 2020

Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells.

1 reference

12 December 2020

Radical surgery for gallbladder cancer: current options

1 reference

12 December 2020

Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region

1 reference

12 December 2020

Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.

1 reference

12 December 2020

Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis

1 reference

12 December 2020

Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa

1 reference

12 December 2020

The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells

1 reference

12 December 2020

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

12 December 2020

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

12 December 2020

Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines

1 reference

12 December 2020

[Establishment and characterization of a human gall bladder carcinoma cell line NOZ].

1 reference

12 December 2020

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

12 December 2020

Focus on lymphangiogenesis in tumor metastasis.

1 reference

12 December 2020

The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995.

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

12 December 2020

VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.

1 reference

12 December 2020

Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma

1 reference

12 December 2020

Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas

1 reference

12 December 2020

Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs)

1 reference

12 December 2020

VEGF receptor expression and signaling in human bladder tumors

1 reference

12 December 2020

Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor

1 reference

12 December 2020

Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma

1 reference

12 December 2020

Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.

1 reference

12 December 2020

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

1 reference

12 December 2020

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.

1 reference

12 December 2020

Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells

1 reference

12 December 2020

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

1 reference

12 December 2020

Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma

1 reference

12 December 2020

The role of lymph node dissection in the treatment of gallbladder carcinoma

1 reference

12 December 2020

Chinese Journal of Oncology

9

32

190

L Jiang

2010

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0562-Y

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

21 June 2024

13

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0562-Y

21 June 2024

Identifiers

1 reference

13 September 2017

1 reference